MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2017 International Congress

    Motor complications and others of therapy but not non-motor symptoms burden predict short-term mortality in non-demented Parkinson´s disease patients

    D. Santos García, E. Suárez Castro, I. Expósito Ruíz, C. Tuñas Gesto, M. Aneiros Díaz, M. López Fernández, T. de Deus, D. Núñez Arias, J. Ernández (Ferrol, Spain)

    Objective: To identify independent risk factors of mortality in a community-based Parkinson´s disease (PD) cohort during prospective long-term follow-up. Specifically, we analized the effect of…
  • 2017 International Congress

    Non-motor features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort .

    M. Stamelou, C. Koros, A. Simitsi, I. Beratis, X. Geronicola Trapali, D. Papadimitriou, N. Papagiannakis, A. Prentakis, D. Kontaxopoulou, S. Fragkiadaki, R. Antonelou, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T SNCA-related PD patients as compared to sporadic PD (sPD) patients. Background: p.A53T α-synuclein (SNCA) mutation…
  • 2017 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD). Background:…
  • 2017 International Congress

    NonMotor and Motor symptoms in Idiopathic Parkinson´s Disease and Secondary parkinsonism The “Parkinsons Well-Being MapTM” – a useful instrument in Clinical praxis.

    Ö. Skogar, M. Nilsson, S. Morberg (Jönköping SWEDEN, Sweden)

    Objective: To evaluate self-reported frequency and amplitude of the spectra of motor (MS) and Non Motor Symptoms (NMS) presented in the “Parkinsons Well-Being MapTM ”…
  • 2017 International Congress

    Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study

    A. Križnar, N. Zupančič Križnar, M. Kramberger, J. Bon, R. Rajnar, L. Ocepek, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To follow up the effect of continuous levodopa-carbidopa intestinal gel infusion (LCIG) on motor and non-motor symptoms in advanced Parkinson’s disease (aPD). Background: Non-motor…
  • 2017 International Congress

    Substantial psychiatric symptoms, sleep disturbances and reduced quality of life in well-treated adult patients with GTP-cyclohydrolase deficient dopa-responsive dystonia

    A. Kuiper, E. Timmers, M. Smit, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study was to systematically investigate the prevalence of psychiatric disorders, sleep problems and health-related quality of life (HRQoL) in patients…
  • 2016 International Congress

    Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?

    M. Hahne, D. Hartmann, C. Thomopoulos, A. Ramih, M. Esther, Y. Guangji, G. Bernd, W. Dirk, R. Heinz, J. Wolfgang (Bad Neustadt, Germany)

    Objective: To compare blood pressure (BP) changes in nighttime by continuous twenty four hour blood pressure monitoring (RR) as a postulated tool to describe sleep…
  • 2016 International Congress

    Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study

    L. R'Bibo, N.E. Mencacci, A. Schrag, J.P. Bestwick, L. Peress, J. Masters, G. Giovannoni, A.J. Lees, J. Hardy, N.W. Wood, A.J. Noyce (London, United Kingdom)

    Objective: To investigate the association of GBA variants with pre-diagnostic features of Parkinson's disease (PD) within the PREDICT-PD cohort. Background: Subtle motor and non-motor symptoms…
  • 2016 International Congress

    α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

    G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To explore the association between levels of α-synuclein burden and urinary dysfunction in early de novo (untreated) Parkinson's disease (PD) patients. Background: Urinary dysfunction…
  • 2016 International Congress

    The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

    L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)

    Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 63
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley